BridgeBio Pharma, Inc. (BBIO): Weighted Average Diluted Shares
191.53M
Year ended 2025-12-31
+9.1%
3-year compound annual growth
+10.2%
5-year compound annual growth
| Period ended | Weighted Average Diluted Shares | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | 191.53M | +2.9% | 2026-02-24, From 2025-01-01 |
| 2024-12-31 | 186.08M | +14.3% | 2026-02-24, From 2024-01-01 |
| 2023-12-31 | 162.79M | +10.4% | 2026-02-24, From 2023-01-01 |
| 2022-12-31 | 147.47M | +2.2% | 2025-02-20, From 2022-01-01 |
| 2021-12-31 | 144.36M | +22.3% | 2024-02-22, From 2021-01-01 |
| 2020-12-31 | 118.00M | n/a | 2023-02-23, From 2020-01-01 |